Interest in {dimethyltryptamine | copyright | this compound ) is certainly sparking a growing dialogue across Canada. Formerly viewed as the periphery of study , copyright is now attracting wider scrutiny from academics, practitioners , and the community. Regulatory policies surrounding its prosp